• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用新型慢病毒载体对范科尼贫血C组造血细胞进行功能校正。

Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.

作者信息

Yamada K, Olsen J C, Patel M, Rao K W, Walsh C E

机构信息

UNC Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

出版信息

Mol Ther. 2001 Apr;3(4):485-90. doi: 10.1006/mthe.2001.0287.

DOI:10.1006/mthe.2001.0287
PMID:11319908
Abstract

Lentiviral vectors transduce nondividing hematopoietic cells more efficiently than other currently available vector systems. Here we report the results of human hematopoietic cell gene transfer using lentiviral vectors based upon human immunodeficiency virus (HIV-1) and equine infectious anemia virus (EIAV). EIAV is a nonprimate lentivirus and is severely restricted in its host range to horses and closely related equines. We employed the EIAV vector system to test for gene transfer to human Fanconi anemia (FA) hematopoietic cells by comparison with HIV-1- and Moloney murine leukemia virus-based systems. Fanconi anemia is characterized by bone marrow failure secondary to stem cell dysfunction. Fanconi anemia group C EBV-transformed lymphoblasts were transduced with all three viral vectors. Phenotypic correction of FA cells, as measured by mitomycin C drug resistance, was observed with a similar efficiency in all vector systems. This is the first description of lentiviral correction of FA cells and suggests that lentiviral vectors may be useful for FA gene transfer.

摘要

慢病毒载体比目前其他可用的载体系统更有效地转导非分裂造血细胞。在此,我们报告了使用基于人类免疫缺陷病毒(HIV-1)和马传染性贫血病毒(EIAV)的慢病毒载体进行人类造血细胞基因转移的结果。EIAV是一种非灵长类慢病毒,其宿主范围严格限于马和与之密切相关的马科动物。我们采用EIAV载体系统,通过与基于HIV-1和莫洛尼鼠白血病病毒的系统进行比较,来测试向人类范可尼贫血(FA)造血细胞的基因转移。范可尼贫血的特征是继发于干细胞功能障碍的骨髓衰竭。用所有三种病毒载体转导范可尼贫血C组EB病毒转化的淋巴细胞。在所有载体系统中,通过丝裂霉素C耐药性测定,观察到FA细胞的表型校正效率相似。这是对FA细胞慢病毒校正的首次描述,并表明慢病毒载体可能对FA基因转移有用。

相似文献

1
Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.使用新型慢病毒载体对范科尼贫血C组造血细胞进行功能校正。
Mol Ther. 2001 Apr;3(4):485-90. doi: 10.1006/mthe.2001.0287.
2
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.利用重组腺相关病毒载体对人类造血细胞中的范可尼贫血进行表型校正。
J Clin Invest. 1994 Oct;94(4):1440-8. doi: 10.1172/JCI117481.
3
Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.基于HIV和EIAV的载体在转导小鼠和人类造血重建细胞方面的效率比较。
Mol Ther. 2005 Sep;12(3):537-46. doi: 10.1016/j.ymthe.2005.01.022.
4
Retroviral-mediated transduction of the fanconi anemia C complementing (FACC) gene in two murine transplantation models.在两种小鼠移植模型中通过逆转录病毒介导转导范可尼贫血C互补(FACC)基因
Blood Cells Mol Dis. 1995;21(1):56-63. doi: 10.1006/bcmd.1995.0009.
5
Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.混合HIV/MSCV长末端重复序列增强慢病毒载体在人CD34(+)造血细胞中的转基因表达。
Stem Cells. 2001;19(3):236-46. doi: 10.1634/stemcells.19-3-236.
6
Gene therapy for fanconi anemia.范可尼贫血的基因治疗。
Curr Hematol Rep. 2003 Jul;2(4):335-40.
7
Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.用于造血细胞谱系基因转移的马传染性贫血衍生载体的优化。
Gene Ther. 2005 Jan;12(1):22-9. doi: 10.1038/sj.gt.3302350.
8
Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.影响HIV-1衍生慢病毒载体对人CD34(+)细胞进行稳定转导的关键因素。
Mol Ther. 2000 Jul;2(1):71-80. doi: 10.1006/mthe.2000.0094.
9
Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.经低剂量照射预处理后,用范可尼贫血C基因转导的恒河猴外周血祖细胞的持续低水平植入。
Mol Ther. 2001 Jun;3(6):911-9. doi: 10.1006/mthe.2001.0337.
10
A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy.
Gene Ther. 1997 Apr;4(4):339-45. doi: 10.1038/sj.gt.3300384.

引用本文的文献

1
Gene Therapy Applications of Non-Human Lentiviral Vectors.非人类慢病毒载体的基因治疗应用。
Viruses. 2020 Sep 29;12(10):1106. doi: 10.3390/v12101106.
2
Insights into neurogenesis and aging: potential therapy for degenerative disease?神经发生与衰老的见解:对退行性疾病的潜在疗法?
Future Neurol. 2010 Jul 1;5(4):527-541. doi: 10.2217/FNL.10.33.
3
Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.使用安全修饰的慢病毒载体对人范可尼贫血补体组 A 骨髓细胞进行临床前矫正。
Gene Ther. 2010 Oct;17(10):1244-52. doi: 10.1038/gt.2010.62. Epub 2010 May 20.
4
The Fanconi anemia pathway and ubiquitin.范可尼贫血通路与泛素
BMC Biochem. 2007 Nov 22;8 Suppl 1(Suppl 1):S10. doi: 10.1186/1471-2091-8-S1-S10.
5
In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.范可尼贫血患者基因校正骨髓细胞的体内再增殖能力。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2340-5. doi: 10.1073/pnas.0510613103. Epub 2006 Feb 6.
6
Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.将基因导入原代T细胞:高效腺病毒转导转基因模型的概述与表征
Immunol Res. 2002;26(1-3):131-41. doi: 10.1385/ir:26:1-3:131.
7
Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.源自马传染性贫血病毒和1型人类免疫缺陷病毒的慢病毒载体所实现的基因转移效率和基因表达水平的比较。
J Virol. 2002 Feb;76(3):1510-5. doi: 10.1128/jvi.76.3.1510-1515.2002.